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It is well established that thestromalcell plays akeyrole in the intramarrowdifferen-
tiation of hemopoietic cells (1). In fact, it was shown that the cell layer consisting
ofa single stromal cell clone is sufficient forsupporting the B cell development from
a single hemopoietic precursor (2). Recently, as the firstnovel molecule isolated from
the stromal cell clone, the complementary DNA of pre-B cell proliferation factor,
lymphopoietin 1 (LP-1)/IL-7, was cloned (3). Previous studies, however, suggested
strongly that the stromal cell-dependent B cell development is a process requiring
a set of molecules expressed on stromal cells (4-6); meaning the actual role ofIL-7
canproperly be assessed only in the environment where it is working. Here, we selected
two stromal cell clones, ST2 (6, 7) and PA6 (8) (the former can support B lymphoi-
esis while the latter can not), and demonstrated that IL-7 is an essential factor that
determines the stromal cell's ability to support B lymphopoiesis.
Materials and Methods
Cell Lines and Cell Culture.
￿
Stromal cell clones PA6 and ST2 and stromal cell-dependent
B cell clone DW34 were described in our previous reports (6-8). The medium used for cul-
turing bone marrow cells on the stromal cell layers was RPMI 1640 (Gibco Laboratories,
Grand Island, NY)supplemented with 5% FCS(lot no. 1115741;HyClone Laboratories,Logan,
UT), 5 x 10-5 M 2-ME, 50 jig/ml streptomycin, and 50 U/ml penicillin (Meiji Seika Co.
Ltd., Tokyo, Japan). The procedurefor culturingbone marrow cells on the stromal cell layer
and cell analysis by flow cytometer was described previously (6, 7).
IL-7 Gene and rIL-7
￿
Poly(A)' RNA was isolated from ST2, which was incubated with
1 pg/ml LPS, Escherichia coli 055:B5 (Difco Laboratories, Detroit, MI) and 1 ng/m14-phorbol-
12-myristate-13-acetate (TPA; Sigma Chemical Co., St. Louis, MO) for 3 d, and used for
theconstruction ofa cDNA expression library accordingto Aruffo andSeed (9). Thelibrary
was screened by a colony filter hybridization procedure with synthetic mouse IL-7 probes
prepared accordingto thepublished sequence (3). Sequencesof theprobes are5' AGCTTTTC-
TAAATCGTGCTCGCAAGTTGAAGCAATTTCTTAAAATGAATATCAGTGAAG 3' and
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5' AATTCTTCACTGATATTCATTTTAAGAAATTGCTTCAACTTGCGAGCAGCAC-
GATTTAGAAA 3'. The Pst I/XmnI fragment from the IL-7 cDNA clone, CDMmIL7, was
subcloned into the expression vector, pCDL-SRa (10), and the resulting clone was desig-
nated pSRa mIL-7 . rIL-7 was obtained as a culture supernatant of COS 1 cells that were
transfected with pSRa mIL7 by a calcium phosphate method 3 d previously. The superna-
tant was used at a dilution of 5%.
Northern Blot Analysis.
￿
Total cellular RNA was isolated from various cells by the guani-
dinium/CsCl method and poly(A)' RNA was purified by oligo-dT-cellulose column chro-
matography. 2 tig of each poly(A)' RNA sample was subjected to electrophoresis on a 1%
agarose/formaldehyde gel, transferred to a nylon membrane (Gene Screen, New England
Nuclear, Boston, MA), and hybridized with the IL-7 probe. The same filter was rehybridized
with the IL-6 probe (11) (a kind gift of Dr. J. van Snick, Ludwig Institute for Cancer Re-
search, Bruxelles, Belgium) or the Cp, probe as controls.
Results and Discussion
To obtain the cDNA clone encoding the IL-7 gene, we prepared a cDNA library
of ST2, which was stimulated with LPS and TPA by using the CDM8 expression
vector (9) . The library was screened by the oligonucleotide probe prepared according
to the sequence ofthe IL-7 coding region reported by Namen et al. (3). Four clones
out of 160,000 recombinant colonies were isolated and the longest clone, CDMmIL7,
having a 2.6-kb insert (Fig. 1), was further characterized. This clone was identical
with that reported by Namen et al. (3), except for its 1-kb longer 3' noncoding re-
gion, and corresponded to the dominantly expressed mRNA species in the stromal
cell clones and organs, including thymus, spleen, and kidney. This confirmed that
multiple IL-7 mRNA species are functional products arisen from the use of an alter-
native splicing site and/or polyadenylation site. Next we recloned the IL-7 coding
region into the expression vector pCDL-SRa (10), and the resulting clone, desig-
nated pSRa mIL7, was transfected into COS-1 cells. The supernatant of the cells
was assayed for IL-7 activity by using stromal cell-dependent pre-B cell line DW34
(6) and also by normal bone marrow cells. The supernatant effectively induced the
proliferation of DW34 cells and stimulated normal bone marrow cells to form colo-
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FIGURE 1.
￿
Restriction map and derivation of the probe of the mouse IL-7 cDNA. (a) Clone
1046 represents the murine IL-7 cDNA clone isolated by Namen et al. (3). The open box and
the filled box illustrate the leader sequence and mature IL-7, respectively. Oligonucleotide probes
for the screening of ST2 stromal cell line cDNA library were synthesized based on the nucleotide
sequence ofclone 1046. (b) CDMmIL7 respresents the cDNA cloneisolated from the ST2 cDNA
library. The restriction map around the IL-7 coding sequence is identical to that of clone 1046.
CDMmIL7 contains an extended 3' noncoding region that is lacking in clone 1046. (c) ForNorthern
blot analysis ofIL-7 transcripts, the Pvu II restriction fragment ofCDMmIL7 was used as the
probe. Pv, Pvu II, Ps, Pst 1, E, Eco RI, C, Cla I, Xm, Xmn I, H, Hind III, Xh, Xho I, Xb, Xba I.
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nies that consisted of B220+ lymphoid cells (data not shown) . Thus, we concluded
that the factor produced by pSRtx mIL-7 is IL-7 .
Using the Pvu II/Pvu II fragment shown in Fig. 1 as the IL-7 probe, we carried
out Northern blot analysis of IL-7 and IL-6 mRNA from two stromal cell clones,
ST2 and PA6 (Fig . 2) . Both of the stromal cell clones did not express IL-7 mRNA
constitutively (Fig. 2, lanes 1 and 5) . When ST2 was stimulated with LPS/TPA or
human HL-la, however, IL-7 mRNA became detectable (Fig . 2, lanes 2 and 3) .
On theother hand, IL-7 mRNA remained undetectable in PA6after the same stimuli,
while IL-6 mRNA was detectable on the same filter (Fig . 2, lanes 6 and 7) . This
result indicates that the producibility of IL-7 correlates well with the stromal cell
ability to support B lymphopoiesis . Moreover, it should be noted that even in ST2,
which supports B lymphopoiesis, IL-7 synthesis is inducible rather than constitutive.
This observation lead us to the question of why the IL-7-dependent B cell line
DW34 can grow on ST2, which does not produce IL-7 constitutively . Themost straight-
forward explanation is that DW34 itself can activate ST2 to produce IL-7 . To test
this possibility, we cultured 2 x 106 DW34 cells on the ST2 layer for 3 d, separated
DW34 cells from the adherent ST2 layer by gentle pipetting, prepared poly(A)+
RNA from each fraction, and measured the level of IL-7 mRNA . As shown in Fig .
2, DW34 did induce the expression of IL-7 mRNA in ST2 more effectively than
IL-1 (lane 4), whileDW34 in the same culture could not produce IL-7 mRNA (lane
8) . Because 25% of themRNA from the adherent ST2 layer was derived from con-
taminated DW34 cells, as estimated by the DW34-specific Cp, message (data not
shown), the level of IL-7 mRNA actually induced by DW34 may be higher than
FIGURE 2 .
￿
Analysis of IL7 mRNA, expressed
in stromal cellclones cultured undervarious con-
ditions. ST2 or PA6wasgrown to the confluency
in aT75 culture flask. The confluent stromal cell
layer was then cultured for three more days in
the absence (lanes 1 and 5) or presence of 1 hg/ml
LPS plus 5ng/mlTPA (lanes 2and 6), or 1 U/ml
of human rIL ltx (lanes 3and 7) . The ST2 layer
was also stimulated with 2 x 10 6 of DW34
cells/flask (lane 4) . After3dofcoculture, DW34
cells were removed from the ST2 layer by gentle
pipetting andwere collected separately from the
adherent cell population (lane 8). Approximately
25% ofmRNA from the adherent ST2 layer was
derived from DW34 cells . This estimation was
carried out by hybridizing the same filter with
the CA probe, which is specific to the B cell (data
not shown) . 2 Wg of poly(A)' mRNA was sub-
jected to electrophoresis.336
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FIGURE 3 .
￿
Induction of matureB cells by IL-7 on the non-B supportive stromal cell clone PA6 .
2 x 106 normal BALB/c bone marrow cells were cultured on the PA6 layer. 2 wk later, the total
cells were harvested and 106 of them were cultured successively in various conditions : (a) IL-7
alone (5% supernatant ofCOS 1 cells transfected with pSRa mIL7) ; (b) on the PA6 layer in
the presence of5% the supernatant ofCOS 1 cell transfected with pCDL-SRci (vector without
IL-7 cDNA insert); (c) on thePA6 layer in the presence of IL-7 ; or (d) on the ST2 layer (A) Cell
recovery 3 wk after the initiation of the secondary culture . (B) Light scatter analysis of the cells
generated in the cultures . Majority of the lymphocytes distribute in the left-lower square (lym-
phocyte gate) in this analysis . Due to the low cell recovery in the culture with IL-7 alone, this
culture was not further analyzed . (C) Surface phenotype of the lymphocytes generated in the
culture with the PA6 layer in the presence of IL-7 or with the ST2 layer. RA3-6132 (anti-13220 ;
reference 12), Bet 1 (anti-Igh6 .5 ; reference 14) and Mac 1 (anti-C3b1 receptor ; reference 15)
rat mAbs were used for staining.
estimated here . This result indicates that stromal cell-hemopoiesic cell interaction
is not an unidirectional one but that the mutual interaction is, in fact, taking place
as a regulatory event during hemopoiesis .
If IL-7 is actually the only factor determining the abilityof stromal cell to supportSUDO ET AL.
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B lymphopoiesis, addition ofIL-7 to the PA6 layer should render this in vitro envi-
ronment B lymphopoietic. For a suitable cell population to test this possibility, we
chosethebone marrow cellspreculturedon thePA6layerfor 2 wk. This cell popula-
tion can not give rise to mature B cells unless it is transferred on theB lymphopoietic
stromal cell layer, ST2(6). This cell population was transferred and cultured for 3
wk in each condition as follows: IL-7 alone, PA6 and control supernatant, PA6 and
IL-7, or ST2 alone. IL-7 alonecould not induce the proliferation of thebone marrow
cells precultured on the PA6 layer (Fig. 3 A). No lymphoid cells appeared in the
culturewith PA6, instead, myeloid cell proliferation wasmaintained (Fig. 3 B). When
the same cells were cultured on the PA6 layer in the presence of IL-7, the prolifera-
tion of the cells was enhanced, and B220+ cells (12), including mature sIgM + cells,
were generated (Fig. 3, B and C). The same cell population also generated the ma-
ture B lymphocytes on the ST2 layer (Fig. 3, B and C).
These results demonstrate clearly that IL-7 is actually an absolute requisite for
the stromal cell-dependent process of B cell development, and it is predicted that
any stromal cell clones incapable ofproducingIL-7 fail to support B lymphopoiesis.
It has already been shown that IL-7, per se, has an activity to induce the prolifera-
tion ofpre-B cells in normal bone marrow (3, 13). Therefore, there does exist astage
of pre-B cell that can proliferate in response to IL-7 without the aid ofother signals.
Our result that IL-7 alone failed to induce the proliferation of the bone marrow
cells preculturedon the PA6 layer, however, indicates that there should be an earlier
stage of B cell that requires both IL-7 andotherstromal cell signal(s) forthe prolifer-
ation. We propose that stromalcell-dependent B cell development is subdivided into
three stages: the first pro-B stage, which is independent from IL-7, the second early
pre-13 stage, which requires both IL-7 and otherstromal cell signal(s), and thethird
mature pre-B stage, which can proliferate in response to IL-7 alone.
It is of particular interest to note that addition of IL-7 is sufficient for inducing
sIgM+ B cells from the bone marrow cells cultured on IL-7 (-) PA6 stromal cells.
Our recent results further demonstrated that individually harvested IL-7-reactive
colonies generated from normal bone marrow cells in semi-solid methyl-cellulose
medium contained 5-207o sIgM+ cells (Suda et al., submitted for publication).
These results suggest that once B progenitors reach the IL-7-reactive stage on the
stromal cell, further differentiation will occur spontaneously through the cell
proliferation.
In conclusion, IL-7 is an essential molecule to the stromal cell-dependent process
of B cell development. The present study suggests that there are other stromal cell
molecule(s) yet to be identified in the earlier stage of B cell differentiation. Several
kinds of stromal cell clones differing in their function together with recombinant
factors will make a helpful system for elucidating these molecules one by one.
Summary
The role of IL-7 in the stromal cell-dependent B cell development was investigated
using two stromal cell clones, ST2 and PA6; the former supports B lymphopoiesis
while the latter can not. We demonstrate here that: (a) the ability of the stromal
cell clone to produce IL-7 correlates well with the stromal cell activity to support
B lymphopoiesis; (6) IL-7 production by ST2 is inducible rather than constitutive;
(c) the IL-7-dependent B cell itself is a potent inducer of IL-7 production by ST2;
(d)addition ofrIL-7 to thePA6layerrendersthis in vitro environmentBlymphopoietic;338
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and (e) the differentiation from early B progenitor to pre-13 cell requires both IL-7
and other stromal cell molecule(s) yet to be identified.
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